Mod­er­na es­tab­lish­es pub­lic health-fo­cused char­i­ty; FDA ap­proves As­traZeneca di­a­betes drug for pe­di­atric use

To help pro­mote pub­lic health and health­care in un­der­served ar­eas of the world, Mod­er­na will es­tab­lish a char­i­ty with a $50 mil­lion en­dow­ment.

The Cam­bridge, MA-based com­pa­ny an­nounced the board of di­rec­tors’ ap­proval Thurs­day. The foun­da­tion will fo­cus on “char­i­ta­ble, sci­en­tif­ic and ed­u­ca­tion­al en­deav­ors” with an em­pha­sis on pro­mot­ing pub­lic health and the ac­cess to health­care, the press re­lease said. The foun­da­tion will start op­er­a­tions once its sta­tus as a 501(c)(3) is ap­proved.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.